Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Vaughan

Showing results (121-130 of 198) with videos related to

Pageof 20
Sort By:
AACE Clinical Case Reports|November 9, 2020
THE NOVEL USE OF STEREOTACTIC RADIOTHERAPY FOR REMNANT ADRENAL TISSUE IN NELSON SYNDROMEAlexandra N Martirossian, Rojymon Jacob, Kristen O Riley, et al.
Cell Biology International|April 26, 2014
A new bioassay identifies proliferation ratios of fibroblasts and myofibroblastsMelville B Vaughan, Tobi D Odejimi, Tracy L Morris, et al.
British Journal of Cancer|June 1, 1994
Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapyB Vaughan Hudson, G Vaughan Hudson, K A MacLennan, et al.
JACS Au|May 29, 2026
How Perspective Directs Outcomes: The Structure and Function of Deficit and Anti-deficit Framing and Their Relevance to Chemistry EducationElizabeth B Vaughan, Josephine Bicknell, Henry Holleb, et al.
Bioengineering (Basel, Switzerland)|November 25, 2021
Design and Analysis of a Biodegradable Polycaprolactone Flow Diverting Stent for Brain AneurysmsKaitlyn Tidwell, Seth Harriet, Vishal Barot, et al.
Journal of Intellectual Disability Research : JIDR|February 19, 2019
'We've made the best of it. But we do not have a normal life': families' experiences of tuberous sclerosis complex and seizure managementA McDonald, J Goodwin, S Roberts, et al.
BMJ (Clinical Research Ed.)|November 10, 1990
Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma InvestigationS Devereux, T G Selassie, G Vaughan Hudson, et al.
Hematological Oncology|March 1, 1992
Failure of IMVP-16 as second-line treatment for relapsed or refractory high grade non-Hodgkin's lymphomaC De Lord, A C Newland, D C Linch, et al.
Journal of Clinical Pathology|March 1, 1987
Incidence and clinical importance of bone marrow eosinophilia in Hodgkin's disease (BNLI Report No 29). British National Lymphoma InvestigationE A Macintyre, B Vaughan Hudson, G Vaughan Hudson, et al.
British Journal of Cancer|November 1, 1993
Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomyA J Swerdlow, A J Douglas, G Vaughan Hudson, et al.
Pageof 20

Showing results (121-130 of 198) with videos related to

Sort By:
Pageof 20
AACE Clinical Case Reports|November 9, 2020
THE NOVEL USE OF STEREOTACTIC RADIOTHERAPY FOR REMNANT ADRENAL TISSUE IN NELSON SYNDROMEAlexandra N Martirossian, Rojymon Jacob, Kristen O Riley, et al.
Cell Biology International|April 26, 2014
A new bioassay identifies proliferation ratios of fibroblasts and myofibroblastsMelville B Vaughan, Tobi D Odejimi, Tracy L Morris, et al.
British Journal of Cancer|June 1, 1994
Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapyB Vaughan Hudson, G Vaughan Hudson, K A MacLennan, et al.
JACS Au|May 29, 2026
How Perspective Directs Outcomes: The Structure and Function of Deficit and Anti-deficit Framing and Their Relevance to Chemistry EducationElizabeth B Vaughan, Josephine Bicknell, Henry Holleb, et al.
Bioengineering (Basel, Switzerland)|November 25, 2021
Design and Analysis of a Biodegradable Polycaprolactone Flow Diverting Stent for Brain AneurysmsKaitlyn Tidwell, Seth Harriet, Vishal Barot, et al.
Journal of Intellectual Disability Research : JIDR|February 19, 2019
'We've made the best of it. But we do not have a normal life': families' experiences of tuberous sclerosis complex and seizure managementA McDonald, J Goodwin, S Roberts, et al.
BMJ (Clinical Research Ed.)|November 10, 1990
Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma InvestigationS Devereux, T G Selassie, G Vaughan Hudson, et al.
Hematological Oncology|March 1, 1992
Failure of IMVP-16 as second-line treatment for relapsed or refractory high grade non-Hodgkin's lymphomaC De Lord, A C Newland, D C Linch, et al.
Journal of Clinical Pathology|March 1, 1987
Incidence and clinical importance of bone marrow eosinophilia in Hodgkin's disease (BNLI Report No 29). British National Lymphoma InvestigationE A Macintyre, B Vaughan Hudson, G Vaughan Hudson, et al.
British Journal of Cancer|November 1, 1993
Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomyA J Swerdlow, A J Douglas, G Vaughan Hudson, et al.
Pageof 20